BSE filing, NSE: WAKEFIT. Summary written from the filing by ALFA Finder's alert engine.
Wakefit Innovations Ltd: key numbers
- Share price
- ₹135.94
- Market cap
- ₹4,508 Cr
- Revenue (annual)
- ₹1,489 Cr
- Net profit (annual)
- ₹189.2 Cr
- P/E (TTM)
- 23.4×Sector 34.1×
- Promoter holding
- 37.07%+0.19% QoQ
- FII holding
- 14.36%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Wakefit Innovations Ltd
All →Wakefit Innovations Other Announcement
Wakefit Innovations Ltd has submitted the quarterly certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the period ended September 30, 2026.
Wakefit Innovations Employee Stock Options
Wakefit Innovations Limited has granted 2,25,442 employee stock options under its ESOP-2019 plan. These options are exercisable into equity shares at a price of Rs. 1 each.
Wakefit Innovations Management Change
Mr. Kunal Chandel, Senior Manager - Legal and Senior Management Personnel, has resigned from Wakefit Innovations Limited, effective from the close of business on September 24, 2026.
Wakefit Innovations Annual General Meeting
Wakefit Innovations Limited held its 10th Annual General Meeting on September 09, 2026, through video conferencing to discuss and adopt financial matters.
Wakefit Innovations Other Announcement
Wakefit Innovations Ltd is notifying shareholders with unregistered email addresses about how to access the Annual Report and AGM notice. This is a routine compliance communication.
Wakefit Innovations Annual General Meeting
Wakefit Innovations Limited has scheduled its 10th Annual General Meeting for September 09, 2026. The company also submitted its Annual Report for FY 2025-26.
Other employee stock options announcements
All →Indegene Employee Stock Options
Indegene Limited allotted 52,194 equity shares under its ESOP schemes, raising paid-up capital to Rs.48.21 Crore. No cash fund raise is involved, so no event value applies.
Raymond Employee Stock Options
Raymond allotted 1,56,784 equity shares to its ESOP Trust under the Raymond Employees Stock Option Plan 2023. Paid-up capital rose to Rs. 66,73,05,150.
Alivus Life Sciences Employee Stock Options
Alivus Life Sciences allotted 1,95,833 equity shares to an employee who exercised ESOP options under its 2021 scheme. Paid-up capital rises to Rs. 24.59 Crore.
Archean Chemical Industries Employee Stock Options
Archean Chemical allotted 6,143 equity shares to one grantee under its ESOP 2022 on 29-Oct-2026. Paid-up capital rose to 12,34,64,537 shares.
Intellect Design Arena Employee Stock Options
Intellect Design Arena granted 1,83,500 RSUs to 19 associates under its ISOP/RSU 2016 scheme. This ESOP grant carries no transaction value for the event.
- Execution
- Vesting over 1st to 5th year from grant
Edelweiss Financial Services Employee Stock Options
Edelweiss Financial Services allotted 4,42,792 equity shares under its employee stock incentive and appreciation rights plans. No consideration amount is stated, so no event value applies.